Hasegawa Hiromasa, Sugita Yoshihiko, Ochiai Takanaga, Roy Rita Rani, Shimada Katsumitsu, Nagayama Motohiko, Maeda Hatsuhiko
Hard Tissue Pathology Unit, Graduate School of Oral Medicine, Matsumoto Dental University, Shiojiri, Japan.
Department of Oral Pathology/Forensic Odontology, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
J Oral Pathol Med. 2025 Aug;54(7):565-573. doi: 10.1111/jop.70007. Epub 2025 Jun 27.
The incidence of spindle cell/pleomorphic lipomas ranges from 2.2% to 47.2%. Its diagnosis is impeded by its diverse histological features, including adipocytes and myxo-collagenous stroma. Accordingly, we aimed to reexamine oral adipocytic tumors, focusing on RB1-deficient tumors, to reveal the diversity of oral spindle cell lipomas.
We selected 30 cases of spindle cell/pleomorphic lipomas and their mimics from 111 oral adipocytic tumors. Subsequently, we performed analysis using immunohistochemistry for CD34 and RB protein (pRB) and RB1 fluorescence in situ hybridization (FISH) in limited cases.
Among the included cases, 16 were CD34-positive with pRB and/or the RB1 loss. Among them, 15 were spindle cell lipomas (SCLs) with 27% of them being confirmed through FISH in cases where pRB status was mosaic. These included five low-fat SPLs (including one low-fat pleomorphic lipoma), four conventional SCLs, three fibrous SCLs, two myxoid, and one fat-rich SCL. The remaining case was an atypical spindle cell lipomatous tumor. Only prominent spindle cell and myxoid changes showed significant differences between SCL and fibrous lipoma. Two cases, initially identified as spindle cell lipomas, were reclassified as fibrolipoma and lipoma.
Oral spindle cell/pleomorphic lipomas frequently exhibit prominent collagenous stroma, which results in low-fat and fibrous variants that require careful differentiation from fibrous lipomas or non-adipocytic tumors. Given the diverse histological findings, meticulous diagnosis of rare spindle cell lipoma variants and other lipomas in daily surgical pathology is essential. Specifically, it should apply CD34 and retinoblastoma protein immunohistochemistry, as well as RB1 FISH when necessary.
梭形细胞/多形性脂肪瘤的发病率在2.2%至47.2%之间。其多样的组织学特征,包括脂肪细胞和黏液样胶原基质,阻碍了对它的诊断。因此,我们旨在重新审视口腔脂肪细胞性肿瘤,重点关注RB1缺陷型肿瘤,以揭示口腔梭形细胞脂肪瘤的多样性。
我们从111例口腔脂肪细胞性肿瘤中选取了30例梭形细胞/多形性脂肪瘤及其类似物。随后,我们对有限病例进行了CD34和RB蛋白(pRB)免疫组化分析以及RB1荧光原位杂交(FISH)。
在所纳入的病例中,16例CD34阳性且伴有pRB和/或RB1缺失。其中,15例为梭形细胞脂肪瘤(SCL),在pRB状态呈镶嵌性的病例中,27%通过FISH得以确诊。这些包括5例低脂型SPL(包括1例低脂型多形性脂肪瘤)、4例经典型SCL、3例纤维型SCL、2例黏液样型和1例富含脂肪型SCL。其余1例为非典型梭形细胞脂肪瘤样肿瘤。仅显著的梭形细胞和黏液样改变在SCL与纤维脂肪瘤之间显示出显著差异。2例最初被诊断为梭形细胞脂肪瘤的病例被重新分类为纤维脂肪瘤和脂肪瘤。
口腔梭形细胞/多形性脂肪瘤常表现出显著的胶原基质,这导致了低脂型和纤维型变体,需要与纤维脂肪瘤或非脂肪细胞性肿瘤仔细鉴别。鉴于组织学表现多样,在日常手术病理中对罕见的梭形细胞脂肪瘤变体及其他脂肪瘤进行细致诊断至关重要。具体而言,应应用CD34和视网膜母细胞瘤蛋白免疫组化,必要时还应进行RB1 FISH。